
Going once, going twice
The discussion of what constitutes fair value has become quite poignant for J C Flowers, especially with regards to his ill-timed investments into ailing German lenders HSH Nordbank and HRE
As this issue goes to press, Soffin owns more than 47% of real estate lender HRE, which, for the last few months, has just barely survived with more than EUR100bn in state-backed guarantees. According to the will of its now biggest shareholder, HRE will decide on a capital increase on the next general assembly on 2 June to strengthen its equity base and make progress on the direly needed restructuring of the system-critical bank. The new shares will be acquired exclusively by Soffin, which aims at acquiring 90% of HRE. This would enable it to squeeze out the other stakeholders and dilute Flowers' stake in the bank.
A similar situation now also affects HSH Nordbank, another J C Flowers investment, which is likely to decide on a capital increase of EUR3bn. According to press reports, J C Flowers seeks legal action against the decision, fearing a massive dilution of its 25% stake due to the low valuation of the shares to be issued. HSH Nordbank is majority-owned by the counties of Hamburg and Schleswig-Holstein, which might expand their joint stake to as much as 85%.
One of Flowers' arguments against selling its stake in HRE when the takeover offer was issued was that the bank would recover in the mid-term and that the stake therefore would be worth much more. The German government argues that the current share price of HRE values Flowers' stake at a fraction of what the investor paid for it.
The government is at the core of the fair value debate, which in theory is a good concept, but in practice is near impossible. When the going price is distressed, does that then constitute the fair value?
Yours sincerely,
Mareen Goebel
Editor, Deutsche unquote"
Tel: +44 20 7004 7462
mareen.goebel@incisivemedia.com
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater